Aspirin-sensitive asthma and upper airway diseases

American Journal of Rhinology and Allergy

Volumn 26, Issue 1, 2012, Pages 27-30

  Chang, Jinny E ^a   Chin, William ^a   Simon, Ronald ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; KETOROLAC;

ASPIRIN EXACERBATED RESPIRATORY DISEASE; DESENSITIZATION; DRUG RECHALLENGE; DRUG TOLERANCE; HUMAN; MAINTENANCE THERAPY; PATHOPHYSIOLOGY; REVIEW;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ASTHMA, ASPIRIN-INDUCED; DESENSITIZATION, IMMUNOLOGIC; DRUG DOSAGE CALCULATIONS; HUMANS; IMMUNIZATION; KETOROLAC; RESPIRATORY TRACT DISEASES;

EID: 84857753333     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3721     Document Type: Review

References (43)

1. Samter M, and Beers RF Jr. Intolerance to aspirin: Clinical studies and consideration of its pathogenesis. Ann Intern Med 68:975-983, 1968.
2. Berges-Gimeno MP, Simon RA, and Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89:474, 2002.
3. Szczeklik A. Aspirin-induced asthma as a viral disease. Clin Allergy 18:15-20, 1998.
4. Szczeklik A, Nizankowska E, and Duplaga M. On behalf of the AIANE investigators: Natural history of aspirin-induced asthma. Eur Respir J 16:432-436, 2000.
5. Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: A case report. Ann. Allergy 62:295-298, 1989. (Pubitemid 19116399)
6. Rodriguez SC, Olguin AM, Miralles CP, and Viladrich PF. Characteristics of meningitis caused by Ibuprofen: Report of 2 cases and review of the literature. Medicine 85:214-220, 2006. (Pubitemid 44107179)
7. Mastalerz L, Setkowicz M, Sanak M, and Szczeklik A. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 113:771-775, 2004. (Pubitemid 38530435)
8. Katial R, Strand M, Prasertsuntarasai T, et al. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J Allergy Clin Immunol 126:738-744, 2010.
9. Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 111:1116-1121, 2003. (Pubitemid 36570875)
10. Woessner KM, Simon RA, and Stevenson DD. The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 46:2201-2206, 2002.
11. Stevenson DD, and Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 108:47-51, 2001. (Pubitemid 32662231)
12. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program Expert Panel Report 3, NIH Publication No. 08-4051, National Heart, Lung, and Blood Institute, Bethesda, MD, 2007. Available online at www.nhlbi.nih.gov/ guidelines/asthma/asthgdln.htm; accessed March 21, 2011.
13. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. National Institutes of Health (NIH), Bethesda, MD, 2008. Available online at www.ginasthma.org; accessed June 1, 2009.
14. Rhinosinusitis Task Force Committee. Report of the Rhinosinusitis Task Force Committee Meeting. Alexandria, Virginia, August 17, 1996. Otolaryngol Head Neck Surg 117:S1-S68, 1997.
15. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: Adult sinusitis. Otolaryngol Head Neck Surg 137:S1-S31, 2007. (Pubitemid 47302529)
16. Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 60:583, 2005.
17. Katotomichelakis M, Riga M, Davris S, et al. Allergic rhinitis and aspirin-exacerbated respiratory disease as predictors of the olfactory outcome after endoscopic sinus surgery. Am J Rhinol Allergy 23:348-353, 2009.
18. Zeiss CR, and Lockey RF. Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 57:440-448, 1976.
19. Bianco S, Tobuschi M, and Petrigni G. Aspirin induced tolerance in aspirin-asthma detected by a new challenge test. IRCS J Med Sci 5:129, 1977. (Pubitemid 8053825)
20. Stevenson DD. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol 24:159-168, 2003.
21. Pfaar O, and Klimek L. Eicosanoids, aspirin-intolerance and the upper airways-Current standards and recent improvements of the desensitization therapy. J Physiol Pharmacol 57(suppl 12):5-13, 2006. (Pubitemid 46569824)
22. Milewski M, Mastalerz L, Nizankowska E, and Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 101:581-586, 1998.
23. Nizankowska E, Bestynska-Krypel A, Cmiel A, and Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirininduced asthma. Eur Respir J 15:863-869, 2000. (Pubitemid 30321842)
24. Parikh AA, and Scadding GK. Intranasal lysine-aspirin in aspirinsensitive nasal polyposis: a controlled trial. Laryngoscope 115:1385-1390, 2005. (Pubitemid 41105844)
25. Mathison DA, and Stevenson DD. Hypersensitivity to nonsteroidal anti-inflammatory drugs: Indications and methods for oral challenges. J Allery Clin Immunol 64:669-674, 1977.
26. Pleskow WW, Stevenson DD, Mathison DA, et al. Aspirin desensitization in aspirin-sensitive asthmatic patients: Clinical manifestations and characterization of refractory period. J Allergy Clin Immunol 69:11-19, 1982. (Pubitemid 12210227)
27. Phillips GD, Foord R, and Holgate ST. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: Its repeatability, absence of a late phase reaction, and the role of histamine J Allergy Clin Immunol 84:232-241, 1989. (Pubitemid 19223135)
28. Millewski M, Mastalerz L, Nizankowska E, and Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 101:581-586, 1998.
29. Patriarca G, Nucera E, Schinco G, et al. Prevention of relapse in nasal polyposis. Lancet 337:1488, 1991.
30. Nucera E, Schiavino D, Milani A, et al. Effects of lysine- acetylsalicylate (LAS) treatment in nasal polyposis: Two controlled long term prospective follow up studies. Thorax 55(suppl 2):S75-S78, 2000.
31. Parikh AA, and Scadding GK. Intranasal lysine-aspirin in aspirin sensitive nasal polyposis: A controlled trial. Laryngoscope 115:1385, 2005.
32. Lee RU, White AA, Ding D, et al. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 105:130-135, 2010.
33. Williams A, Woessner KM, Simon RA, and Stevenson DD. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol 120:273-277.
34. Macy E, Bernstein JA, Castells MC, et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: A practice paper. Ann Allergy Asthma Immunol 98:172-174, 2007. (Pubitemid 46214224)
35. White AA, Stevenson DD, and Simon RA. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 95:330-335, 2005. (Pubitemid 41483726)
36. White A, Bigby T, and Stevenson DD. Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 97:190-195, 2006. (Pubitemid 44272585)
37. Horse W. Surgical treatment of nasal polyposis in patients with aspirin intolerance. Thorax 55(suppl 2):S87-S90, 2000.
38. McMains KC, and Kountakis SE. Medical and surgical considerations in patients with Samter's triad. Am J Rhinol 20:573-576, 2006. (Pubitemid 44963816)
39. Klimek L, and Pfaar O. Aspirin intolerance: Does desensitization alter the course of the disease? Immunol Allergy Clin North Am 29:669-675, 2009.
40. Berges-Gimeno MP, Simon RA, and Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirinexacerbated respiratory disease. J Allergy Clin Immunol 111:180-186, 2003. (Pubitemid 36143311)
41. Gosepath J, Schaefer D, Amedee RG, and Mann WJ. Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 127:316-321, 2001. (Pubitemid 32205391)
42. Rozasi A, Polzehl D, Deutschle T, et al. Long-term treatment with aspirin desensitization: A prospective clinical trial comparing100mg and 300mg aspirin daily. Allergy 63:1228-1234, 2008.
43. Lee JA, Simon RA and Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 119:157, 2007.